Stock listing
Lang & Schwarz:A40L5C Exicure, Inc. Aktie
German listing (Lang & Schwarz) of Exicure, Inc. · home listing NASDAQ:XCUR
Follow Exicure, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:XCUR
$1.01 USD +0.08 (+8.0%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:XCUR
- Day range
- $0.944 – $1.06 USDOct 30, 2026
- Volume
- 28,127 sharesOct 30, 2026
- Market cap
- $6.61M USDAt the close on Oct 30, 2026 · price × 6.55M shares outstanding
- 52-week range
- $0.90 – $9.48 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $55,900 USDMedian day 27,964 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:XCUR · Home | $1.01 USD | +0.075 (+8.0%) | 28,127 | $0.944 | $1.06 | $0.944 | $0.935 | Close on Oct 30, 2026 |
| Frankfurt:2H0 | €0.79 EUR | -0.025 (-3.1%) | — | €0.79 | €0.79 | €0.79 | €0.815 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:XCUR · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.01 | +0.075 | +8.0% | $0.944 | $1.06 | $0.944 | 28,127 | |
| $0.935 | -0.082 | -8.0% | $1.05 | $1.09 | $0.90 | 41,350 | |
| $1.017 | -0.054 | -5.0% | $1.08 | $1.13 | $1.01 | 24,691 | |
| $1.07 | -0.02 | -1.8% | $1.095 | $1.095 | $1.04 | 12,325 | |
| $1.09 | +0.04 | +3.8% | $1.06 | $1.09 | $1.02 | 35,998 | |
| $1.05 | -0.08 | -7.1% | $1.10 | $1.14 | $1.04 | 61,200 | |
| $1.13 | +0.12 | +11.9% | $1.15 | $1.28 | $1.08 | 440,000 | |
| $1.01 | +0.011 | +1.1% | $0.984 | $1.05 | $0.971 | 40,600 | |
| $0.999 | -0.031 | -3.0% | $1.11 | $1.11 | $0.99 | 43,800 | |
| $1.03 | -0.09 | -8.0% | $1.12 | $1.30 | $1.029 | 69,100 | |
| $1.12 | 0.00 | 0.0% | $1.214 | $1.214 | $1.08 | 32,700 | |
| $1.12 | -0.09 | -7.4% | $1.21 | $1.24 | $1.10 | 20,600 | |
| $1.21 | +0.06 | +5.2% | $1.16 | $1.26 | $1.16 | 28,300 | |
| $1.15 | +0.06 | +5.5% | $1.12 | $1.21 | $1.09 | 27,800 | |
| $1.09 | +0.04 | +3.8% | $1.09 | $1.10 | $1.06 | 15,200 | |
| $1.05 | +0.05 | +5.0% | $0.95 | $1.10 | $0.936 | 316,500 | |
| $1.00 | -0.02 | -2.0% | $0.99 | $1.05 | $0.99 | 14,800 | |
| $1.02 | -0.06 | -5.6% | $1.04 | $1.04 | $1.00 | 9,200 | |
| $1.08 | +0.01 | +0.9% | $1.11 | $1.11 | $1.07 | 7,300 | |
| $1.07 | -0.08 | -7.0% | $1.14 | $1.19 | $1.07 | 17,700 | |
| $1.15 | -0.03 | -2.5% | $1.17 | $1.18 | $1.15 | 5,300 | |
| $1.18 | -0.01 | -0.8% | $1.17 | $1.18 | $1.11 | 4,400 | |
| $1.19 | +0.05 | +4.4% | $1.279 | $1.279 | $1.123 | 19,900 | |
| $1.14 | -0.095 | -7.7% | $1.195 | $1.195 | $1.14 | 29,300 | |
| $1.235 | +0.015 | +1.2% | $1.23 | $1.235 | $1.17 | 2,600 | |
| $1.22 | -0.01 | -0.8% | $1.22 | $1.23 | $1.21 | 3,200 | |
| $1.23 | -0.01 | -0.8% | $1.24 | $1.28 | $1.215 | 22,900 | |
| $1.24 | -0.05 | -3.9% | $1.25 | $1.29 | $1.23 | 9,300 | |
| $1.29 | +0.03 | +2.4% | $1.30 | $1.30 | $1.21 | 17,100 | |
| $1.26 | +0.03 | +2.4% | $1.24 | $1.34 | $1.21 | 32,100 | |
| $1.23 | -0.12 | -8.9% | $1.33 | $1.40 | $1.23 | 40,000 | |
| $1.35 | +0.02 | +1.5% | $1.36 | $1.419 | $1.285 | 10,300 | |
| $1.33 | +0.02 | +1.5% | $1.26 | $1.36 | $1.22 | 21,200 | |
| $1.31 | -0.06 | -4.4% | $1.285 | $1.325 | $1.27 | 17,600 | |
| $1.37 | -0.03 | -2.1% | $1.35 | $1.405 | $1.33 | 13,900 | |
| $1.40 | +0.03 | +2.2% | $1.40 | $1.43 | $1.341 | 10,500 | |
| $1.37 | -0.06 | -4.2% | $1.41 | $1.41 | $1.255 | 29,700 | |
| $1.43 | +0.02 | +1.4% | $1.45 | $1.60 | $1.37 | 221,400 | |
| $1.41 | +0.16 | +12.8% | $1.31 | $1.54 | $1.31 | 83,800 | |
| $1.25 | +0.02 | +1.6% | $1.23 | $1.28 | $1.22 | 16,800 | |
| $1.23 | -0.06 | -4.7% | $1.30 | $1.301 | $1.22 | 21,700 | |
| $1.29 | -0.01 | -0.8% | $1.24 | $1.32 | $1.23 | 15,100 | |
| $1.30 | -0.01 | -0.8% | $1.28 | $1.30 | $1.23 | 16,600 | |
| $1.31 | +0.02 | +1.6% | $1.31 | $1.35 | $1.285 | 21,800 | |
| $1.29 | -0.12 | -8.5% | $1.40 | $1.40 | $1.29 | 18,900 | |
| $1.41 | +0.15 | +11.9% | $1.28 | $1.46 | $1.28 | 102,100 | |
| $1.26 | +0.07 | +5.9% | $1.19 | $1.29 | $1.19 | 29,700 | |
| $1.19 | +0.04 | +3.5% | $1.15 | $1.23 | $1.13 | 19,200 | |
| $1.15 | 0.00 | 0.0% | $1.15 | $1.20 | $1.08 | 28,800 | |
| $1.15 | -0.15 | -11.5% | $1.32 | $1.32 | $1.05 | 151,700 | |
| $1.30 | -0.15 | -10.3% | $1.44 | $1.45 | $1.30 | 39,000 | |
| $1.45 | +0.02 | +1.4% | $1.45 | $1.49 | $1.397 | 25,400 | |
| $1.43 | +0.05 | +3.6% | $1.35 | $1.48 | $1.35 | 28,500 | |
| $1.38 | +0.13 | +10.4% | $1.26 | $1.42 | $1.26 | 52,200 | |
| $1.25 | -0.06 | -4.6% | $1.33 | $1.33 | $1.25 | 21,900 | |
| $1.31 | +0.01 | +0.8% | $1.31 | $1.35 | $1.18 | 54,300 | |
| $1.30 | -0.07 | -5.1% | $1.40 | $1.40 | $1.30 | 17,600 | |
| $1.37 | 0.00 | 0.0% | $1.37 | $1.37 | $1.37 | 37,200 | |
| $1.37 | +0.025 | +1.9% | $1.33 | $1.43 | $1.285 | 59,800 | |
| $1.345 | -0.005 | -0.4% | $1.35 | $1.43 | $1.269 | 40,000 | |
| $1.35 | -0.16 | -10.6% | $1.46 | $1.46 | $1.30 | 56,200 | |
| $1.51 | -0.03 | -1.9% | $1.50 | $1.55 | $1.42 | 28,400 | |
| $1.54 | -0.04 | -2.5% | $1.61 | $1.63 | $1.511 | 70,400 | |
| $1.58 | -0.02 | -1.3% | $1.52 | $1.64 | $1.50 | 52,100 | |
| $1.60 | +0.03 | +1.9% | $1.65 | $1.65 | $1.55 | 17,700 | |
| $1.57 | -0.16 | -9.2% | $1.74 | $1.74 | $1.57 | 64,100 |
- Ticker
- Lang & Schwarz:A40L5C
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Lang & Schwarz
- Currency
- EUR
What changed lately
Latest news release · Sep 16, 2026
Exicure Receives Nasdaq Extension to Regain Compliance with Stockholders’ Equity Requirement
Latest news
Exicure Receives Nasdaq Extension to Regain Compliance with Stockholders’ Equity Requirement
Sep 16, 2026
Closed $1.33 (+1.5%) on Sep 16, 2026
Exicure to Settle GPCR Therapeutics Clinical Milestone Payment Through Equity Issuance
Aug 3, 2026
Closed $1.58 (-1.3%) on Aug 3, 2026
Exicure Announces Board and Committee Changes
Jun 30, 2026
Closed $2.08 (-5.5%) on Jun 30, 2026
Exicure Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders’ Equity Requirement
Jun 10, 2026
Closed $2.82 (+2.2%) on Jun 11, 2026
Exicure Announces Receipt of Nasdaq Delinquency Notice and Filing of Form 10-Q
Jun 1, 2026
Closed $3.11 (-6.6%) on Jun 2, 2026
Exicure Announces Co-Development Agreement with Adbiotech for Burixafor (GPC-100)
Apr 22, 2026
Closed $3.64 (+0.1%) on Apr 23, 2026
Exicure, Inc. Reports Full Year 2025 Financial Results
Mar 25, 2026
Closed $4.61 (0.0%) on Mar 26, 2026
Exicure Announces Publication in Annals of Hematology Highlighting Rapid Stem Cell Mobilization with Burixafor in Patients with Multiple Myeloma and Lymphoma Undergoing Transplant
Feb 5, 2026
Closed $4.26 (+4.4%) on Feb 5, 2026
Exicure to Present Data from Burixafor Phase 2 Trial at the 2026 Tandem Meetings
Jan 21, 2026
Closed $6.28 (+2.3%) on Jan 21, 2026
Exicure Presents Positive Topline Phase 2 Data for Burixafor in Multiple Myeloma at 2025 ASH Annual Meeting
Dec 8, 2025
Closed $7.29 (+36.8%) on Dec 9, 2025
Decks
Investor Presentation (January 2022)
Investor deck · 23 slides · Jan 5, 2022
Investor Presentation (August 2021)
Investor deck · 42 slides · Aug 5, 2021
Investor Presentation (April 2021)
Investor deck · 39 slides · Apr 9, 2021
Investor Day (January 2021)
Investor day · 72 slides · Jan 7, 2021
Exicure, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 12 in the last 12 months · 117 in all · newest Sep 16, 2026 · oldest 2019
- Decks
- 6 decks · latest Jan 5, 2022
Where Exicure, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:XCUR · Home listing | NASDAQ | United States | USD |
| Munich:2H0 | Munich | Germany | EUR |
| LS Exchange:A40L5C | LS Exchange | Germany | EUR |
| BOATS:XCUR | BOATS | United States | USD |
| Lang & Schwarz:A40L5C · This page | Lang & Schwarz | Germany | EUR |
| gettex:2H0 | gettex | Germany | EUR |
| Frankfurt:2H0 | Frankfurt | Germany | EUR |
| Stuttgart:2H0 | Stuttgart | Germany | EUR |
| Tradegate:2H0 | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about Exicure, Inc.